Metabolic Diseases

Interconnected cardiovascular, renal, and metabolic (CRM) diseases are the leading cause of death worldwide and account for up to 20 million deaths annually.  By following the science, we are targeting specific pathways to address the interconnected nature of these diseases. Building on our expertise in developing innovative treatments for CRM conditions, our goal is to improve the lives of people living with these diseases, their families and the healthcare system.


Boehringer’s Commitment to Metabolic Diseases

Positioning in CRM
Metabolic Diseases

Positioning in Cardiovascular, Renal and Metabolic Diseases

Our mission is to protect people from the consequences of cardiovascular, renal and metabolic diseases, and advocate for a shift from fragmented to integrated solutions that focus on prevention and treatment.
Innovation in CRM diseases
Metabolic Diseases

Innovation in Cardio-Renal-Metabolic Diseases

Cardiovascular, renal and metabolic diseases are connected conditions that can amplify each other. We are dedicated to delivering innovation for people living with these diseases both now, and for future generations.


Latest News on Metabolic Diseases


Patients with cardiovascular, renal and metabolic diseases often have multiple conditions connected by underlying similar pathologies.

Our services

A complete overview of our products for Human Health